Open Access · CC BY 4.0
Retraction: UBE2D3 activates SHP-2 ubiquitination to promote glycolysis and proliferation of glioma via regulating STAT3 signaling pathway
Frontiers in Oncology · 06.11.2026 · 16
DOI: 10.3389/fonc.2026.2038834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 06.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Retraction: UBE2D3 activates SHP-2 ubiquitination to promote glycolysis and proliferation of glioma via regulating STAT3 signaling pathway. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.2038834
Vancouver
Retraction: UBE2D3 activates SHP-2 ubiquitination to promote glycolysis and proliferation of glioma via regulating STAT3 signaling pathway. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.2038834
BibTeX
@article{euvimed2026,
title = {Retraction: UBE2D3 activates SHP-2 ubiquitination to promote glycolysis and proliferation of glioma via regulating STAT3 signaling pathway},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.2038834}
}
EUVIMED